SeeTreat and ImageX NHMRC Grant

SeeTreat is pleased to announce that, in partnership with the Image X Institute at the University of Sydney, we have successfully received a three-year NHMRC Development Grant to build an exciting new AI medical device.

The Development grant scheme expedites the translation of health and medical research outcomes through to commercialisation within a foreseeable timeframe. The funded research will focus on advancing and investigating a novel AI targeted radiation therapy software device that will personalise radiation therapy targeting to improve patient outcomes for lung, liver, and pancreas cancer patients.

SeeTreat's extensive experience in medical device product development will be invaluable throughout the progress of the grant. SeeTreat founders Professor Paul Keall (also the Director of the Image X Institute) and Dr Trang Nguyen (SeeTreat CEO) are the grant's Chief Investigators A and B respectively.